1. Home
  2. NTRA vs CHKP Comparison

NTRA vs CHKP Comparison

Compare NTRA & CHKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • CHKP
  • Stock Information
  • Founded
  • NTRA 2003
  • CHKP 1993
  • Country
  • NTRA United States
  • CHKP Israel
  • Employees
  • NTRA N/A
  • CHKP N/A
  • Industry
  • NTRA Medical Specialities
  • CHKP Computer Software: Prepackaged Software
  • Sector
  • NTRA Health Care
  • CHKP Technology
  • Exchange
  • NTRA Nasdaq
  • CHKP Nasdaq
  • Market Cap
  • NTRA 20.6B
  • CHKP 18.8B
  • IPO Year
  • NTRA 2015
  • CHKP 1996
  • Fundamental
  • Price
  • NTRA $161.01
  • CHKP $189.42
  • Analyst Decision
  • NTRA Strong Buy
  • CHKP Buy
  • Analyst Count
  • NTRA 15
  • CHKP 21
  • Target Price
  • NTRA $152.67
  • CHKP $197.84
  • AVG Volume (30 Days)
  • NTRA 1.2M
  • CHKP 638.3K
  • Earning Date
  • NTRA 11-12-2024
  • CHKP 02-04-2025
  • Dividend Yield
  • NTRA N/A
  • CHKP N/A
  • EPS Growth
  • NTRA N/A
  • CHKP 1.53
  • EPS
  • NTRA N/A
  • CHKP 7.32
  • Revenue
  • NTRA $1,531,955,000.00
  • CHKP $2,524,800,000.00
  • Revenue This Year
  • NTRA $53.71
  • CHKP $8.13
  • Revenue Next Year
  • NTRA $11.00
  • CHKP $5.63
  • P/E Ratio
  • NTRA N/A
  • CHKP $25.71
  • Revenue Growth
  • NTRA 54.94
  • CHKP 5.65
  • 52 Week Low
  • NTRA $58.53
  • CHKP $145.75
  • 52 Week High
  • NTRA $175.63
  • CHKP $210.70
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 45.49
  • CHKP 52.18
  • Support Level
  • NTRA $153.53
  • CHKP $180.75
  • Resistance Level
  • NTRA $172.80
  • CHKP $191.22
  • Average True Range (ATR)
  • NTRA 5.91
  • CHKP 4.29
  • MACD
  • NTRA -2.98
  • CHKP 0.06
  • Stochastic Oscillator
  • NTRA 8.17
  • CHKP 54.45

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About CHKP Check Point Software Technologies Ltd.

Check Point Software Technologies is a pure-play cybersecurity vendor. The company offers solutions for network, endpoint, cloud, and mobile security in addition to security management. Check Point, a software specialist, sells to enterprises, businesses, and consumers. Around 50% of revenue is generated in Europe, the Middle East, and Africa, 40% from the Americas, and 10% from the Asia-Pacific region. The firm, based in Tel Aviv, Israel, was founded in 1993 and has about 5,000 employees.

Share on Social Networks: